This content is machine translated Heart failure: ESC guideline update 2023 Treatment of HFmrEF – what’s new? The European Society of Cardiology (ESC) recently updated its guidelines. Consequently, based on the EMPEROR-Preserved and DELIVER trials, the use of SGLT-2 inhibitors is now recommended for all stages of…
View Post 6 min This content is machine translated Heart failure Dapagliflozin now approved in preserved ejection fraction [1,4]** After dapagliflozin had been approved for some time for heart failure with reduced ejection fraction, Swissmedic now granted an indication extension for heart failure with mildly reduced or preserved ejection…
